Share Name Share Symbol Market Type Share ISIN Share Description
Medical House LSE:MLH London Ordinary Share GB0009246835
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 27.25p 0.00p 0.00p - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 5.1 -1.3 -1.6 - 16.38

Medical House (MLH) Latest News

Real-Time news about Medical House (London Stock Exchange): 0 recent articles
More Medical House News
Medical House Takeover Rumours

Medical House (MLH) Share Charts

1 Year Medical House Chart

1 Year Medical House Chart

1 Month Medical House Chart

1 Month Medical House Chart

Intraday Medical House Chart

Intraday Medical House Chart

Medical House (MLH) Discussions and Chat

Medical House Forums and Chat

Date Time Title Posts
22/11/200908:52Medical House307
31/8/200810:04The Medical House172

Add a New Thread

Medical House (MLH) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Medical House trades in real-time

Medical House (MLH) Top Chat Posts

Medical House Daily Update: Medical House is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker MLH. The last closing price for Medical House was 27.25p.
Medical House has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 60,118,869 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Medical House is £16,382,391.80.
sandbank: NOT SO HASTY: Although the directors of MLH have "irrevocably" committed their shares they've only got 35% of the issued capital. This deal is therefore all down to the shareholders - and the shareholders don't like it one bit. Even the chairman of MLH, Ian Townsend, appears to concede this morning that the offer from Consort Medical is a pretty miserly one. He says "The Offer represents a "good" premium to the share price. His use of the adjective "good" - as opposed to "excellent" or "generous" is - in effect - damning the offer with faint praise. The MLH chairman then says "Like many small companies, the market has not recognised the full value of The Medical House". Damn right. That is an open offer for someone else to mount a rival bid. In fact both companies seem to expect a better bid to materialise. This morning's RNS says the board's "irrevocable" undertakings will still continue to be binding even "if a higher offer is made." The MLH shareholders should not surrender and meekly allow their pockets to be picked.
egoi: Well done Philjeans but I'd caution that there's no mention of a price or of any bid materialising. It would be rather unusual for someone to offer double the market share price, regardless of liquidity.
sleepinggiant: Medical shares rocket By Ros Snowdon SHARES in injection specialist The Medical House leapt over 40 per cent last night on the news the company has received a takeover approach. The Sheffield company saw its shares rise 40.5 per cent, up 7.5p to 26p causing the group to issue a brief statement saying it had received an approach which may or may not lead to an offer for the company. Analysts said the group's low share price makes it vulnerable to a bid. Chairman Ian Townsend was unable to comment on the potential offer due to stock exchange rules, but said the share price increase which precipitated the announcement was on the back of a successful road show in London last week and the company's improved trading performance. Before the announcement was made the shares rose 2.5p on the back of the group's improved performance, but under stock exchange rules the group is required to make any takeover approaches public if the share price rises more than 10 per cent. "I would stress that the process is at a very early stage," said Mr Townsend. "It would be strange if we were not receiving enquiries given the valuable technology we own and our low market cap. The two are out of step." The takeover approach follows the news last week that The Medical House is set to make its first profit this year. The company hit the big time last year with the £34m six-year deal with a major pharmaceutical company which cannot be named for competitive reasons. Now it has signed up a big customer, other global pharma companies are keen to hold talks and the group is confident of signing further significant deals.
mjcrockett: Yes, decent news indeed. Company virtually debt free and trading well. The share price has hardly moved on the results, which is surprising. The market cap is currently around £11 and yet MLH have a £15m of MINIMUM license payments to come over the next 6 years AND there are more contracts to come. MJ
mjcrockett: Medical House tipped in the Independent today:- Medical House Our view: Worth a punt Share price: 38p (+7.5p). Medical House unveiled the biggest licensing deal to date for its AutoSafety syringe yesterday. The company could not say who its partner is, but indicated that it was a global pharmaceutical player. More importantly, the deal is worth £27m to Medical House over the next five years and follows a similar tie-up earlier this year with Swiss group Serono. The AutoSafety syringe is designed to make it easy for patients to administer treatments to themselves and is perfect for those who take regular doses via an injection. Because the needle is hidden from view at all times, patients tend to prefer it over traditional alternatives. The deal is certainly significant for the company when one considers that even after yesterday's share price jump the whole enterprise is valued at just £22m. With momentum building, its stock is worth a punt. Perhaps we could see a further rise today. MJ
whitebicycle: From the Telegraph Questor column. Medical House is a shot in the arm Hands up if you don't like needles! While you are waving your arms in the air, you might like to vote for Medical House, which has managed to do the thing that rival drug delivery companies never managed. Powderject and Weston Medical were two companies that were founded on the dream of producing needle-free technologies, but neither of them delivered. Weston went bust, and Powderject, rather cleverly, used its much-hyped share price to buy vaccines that would actually sell. So it has been up to Medical House to pioneer a needle-free syringe, as well as more standard retractable needle technology. The NHS already uses its syringes for some insulin, although sales have been disappointing. However, a deal this week makes the company look a whole lot more exciting. It has hooked up with a large drug company (no names) that wants to launch a drug using the Medical House technology. The deal, we are told, is worth a minimum of $7.5m, which is transformative for a company with a market capitalisation of £34m. It hopes more will follow. As well as the space-age stuff, Medical House has a small business making orthopaedic instruments for hip replacement that provides most of its turnover. Yesterday the business announced full-year sales of £5.6m against £5.2m, while losses narrowed slightly to £479,000. Analysts expect a profit in 2006. The shares rose 2.5 to 59.5p. The risks with this company are the same as for any tiny business. If things go wrong, they go very, very wrong - and big drug companies are not known for their kindness to their weaker brethren. But if you don't mind being at the sharp end, Medical House might be worth a shot.
helllv: The sooner Medisys are out the way the sooner the share price will recover .
morraly bankrupt: The share price drop has been on non-existent volumes. Some weeks there are only two trades and they're usually small punters like me. However, when the MM tried to mark the price up once or twice, he got slaughtered and put it down at once. The Web businesses are said to be profit-making and make up only a small part of the business. I looked at the Dental Web site and it looked awful. Like a kid's homepage project. The main part of the co. is medical instruments, particuarly surgical, although if you read the RNS you will see they have licensed a bug detecting technology from a larger firm who have taken a stake at a price higher than the current Offer price. To be honest, I was going to sell these on first day at 20% profit but I can't sell as I will lose my CGT relief under the EIS, (do u know what that is?). My only other medical share if SN. which has performed well. I have ten times invested in SN. as I do in Medical House and won't shift any more until results come in. Always treat AIM shares as a punt and no more. Overall, they fit in to my defensive strategy which I am sticking too until the Spring and some clear signals over US interest rates. Good luck, small punt only. DYOR etc.
Medical House share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20161023 23:52:12